Menu Button
About Us
Approach
PNT001 program
Clinical strategy
Tauopathies
News
Press Releases/News
All
2020
2019
May 6, 2020
Pinteon Therapeutics Announces Scientific Advisory Board for Traumatic Brain Injury
October 31, 2019
Pinteon Therapeutics Launches Phase 1 Trial of Novel Tau Antibody that Targets a Potent Driver of Neurodegenerative Disease
May 6, 2020
Pinteon Therapeutics Announces Scientific Advisory Board for Traumatic Brain Injury
October 31, 2019
Pinteon Therapeutics Launches Phase 1 Trial of Novel Tau Antibody that Targets a Potent Driver of Neurodegenerative Disease
About Us
Approach
PNT001 program
Clinical strategy
Tauopathies
News
